Brief: Immunocore Presents New Biomarker Analysis For Kimmtrak

Immunocore Holdings

11/11/2022 14:30

Nov 11 (Reuters) - Immunocore Holdings PLC  IMCR.O :
    * IMMUNOCORE PRESENTS NEW BIOMARKER ANALYSIS FOR KIMMTRAK
(TEBENTAFUSP-TEBN)IN METASTATIC UVEAL MELANOMA AT SITC 2022
ANNUAL MEETING
    * IMMUNOCORE HOLDINGS PLC - EXPRESSION OF GP100 PROTEIN,
TARGET OF
KIMMTRAK, IS UNCHANGED RELATIVE TO BASELINE INBIOPSIES AT TIME
OF TUMORPROGRESSION
    * IMMUNOCORE HOLDINGS PLC - PATIENTS WITH RADIOGRAPHIC
PROGRESSION
WHO RETAIN EXPRESSION OF ANTIGEN PROCESSING MACHINERY HAVE LONG
SURVIVAL

Source text for Eikon:  ID:nGNX8jnH3H 
Further company coverage:  IMCR.O 
 ((reuters.briefs@thomsonreuters.com;))